Rat prenatal Cannabis smoke exposure

[1]  Timothy J. Onofrychuk,et al.  Repeated Exposure to High-THC Cannabis Smoke during Gestation Alters Sex Ratio, Behavior, and Amygdala Gene Expression of Sprague Dawley Rat Offspring , 2023, eNeuro.

[2]  R. McLaughlin,et al.  Determining impacts of prenatal cannabis exposure on cannabis vapor self-administration using a novel response-contingent vapor model in pregnant rat dams , 2023, Addiction Neuroscience.

[3]  E. Bates,et al.  Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, cognition, and prefrontal cortex excitability , 2022, bioRxiv.

[4]  D. Hardy,et al.  Prenatal THC Exposure Induces Sex-Dependent Neuropsychiatric Endophenotypes in Offspring and Long-Term Disruptions in Fatty-Acid Signaling Pathways Directly in the Mesolimbic Circuitry , 2022, eNeuro.

[5]  Yan Zhang,et al.  Regulation and Function of Chemokines at the Maternal–Fetal Interface , 2022, Frontiers in Cell and Developmental Biology.

[6]  O. Manzoni,et al.  In utero exposure to cannabidiol disrupts select early-life behaviors in a sex-specific manner , 2022, bioRxiv.

[7]  Timothy J. Onofrychuk,et al.  The effects of acute Cannabis smoke or Δ9-THC injections on the trial-unique, nonmatching-to-location and five-choice serial reaction time tasks in male Long-Evans rats , 2022, Neurobiology of Learning and Memory.

[8]  M. Soares,et al.  Modeling Trophoblast Cell-Guided Uterine Spiral Artery Transformation in the Rat , 2022, International journal of molecular sciences.

[9]  A. Reece,et al.  Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015 , 2022, BMC Pediatrics.

[10]  A. Masoud,et al.  Birth Outcomes of Neonates Exposed to Marijuana in Utero , 2022, JAMA network open.

[11]  Y. Hurd,et al.  Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring , 2021, Proceedings of the National Academy of Sciences.

[12]  L. C. Bidwell,et al.  A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment , 2021, Psychopharmacology.

[13]  N. Teixeira,et al.  Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts , 2021, Archives of Toxicology.

[14]  R. McLaughlin,et al.  Pharmacokinetics and central accumulation of delta-9-tetrahydrocannabinol (THC) and its bioactive metabolites are influenced by route of administration and sex in rats , 2021, Scientific Reports.

[15]  H. Bradshaw,et al.  Perinatal CBD or THC Exposure Results in Lasting Resistance to Fluoxetine in the Forced Swim Test: Reversal by Fatty Acid Amide Hydrolase Inhibition. , 2021, Cannabis and cannabinoid research.

[16]  Y. Hurd,et al.  Cannabis and synaptic reprogramming of the developing brain , 2021, Nature Reviews Neuroscience.

[17]  E. Weerts,et al.  Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations , 2021, Psychopharmacology.

[18]  M. Perreault,et al.  Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents , 2021, Schizophrenia bulletin open.

[19]  M. Rotermann.  Looking back from 2020, how cannabis use and related behaviours changed in Canada. , 2021, Health reports.

[20]  R. McLaughlin,et al.  Maternal‐fetal transmission of delta‐9‐tetrahydrocannabinol (THC) and its metabolites following inhalation and injection exposure during pregnancy in rats , 2021, Journal of neuroscience research.

[21]  S. Kitaoka,et al.  Maternal and Fetal Pharmacokinetic Analysis of Cannabidiol during Pregnancy in Mice , 2021, Drug Metabolism and Disposition.

[22]  L. Devi,et al.  Diversity of molecular targets and signaling pathways for CBD , 2020, Pharmacology research & perspectives.

[23]  E. Weerts,et al.  Translational models of cannabinoid vapor exposure in laboratory animals , 2020, Behavioural pharmacology.

[24]  Timothy J. Onofrychuk,et al.  Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg , 2020, The European journal of neuroscience.

[25]  R. McLaughlin,et al.  Long-term effects of maternal cannabis vapor exposure on emotional reactivity, social behavior, and behavioral flexibility in offspring , 2020, Neuropharmacology.

[26]  S. Hawken,et al.  Maternal cannabis use in pregnancy and child neurodevelopmental outcomes , 2020, Nature Medicine.

[27]  Jarrod M. Ellingson,et al.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment. , 2020, JAMA psychiatry.

[28]  N. Teixeira,et al.  The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders , 2020, Human reproduction update.

[29]  D. Hardy,et al.  Maternal exposure to Δ9-tetrahydrocannabinol impairs female offspring glucose homeostasis and endocrine pancreatic development in the rat. , 2020, Reproductive toxicology.

[30]  A. Weller,et al.  The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders , 2020, Current neuropharmacology.

[31]  D. Hardy,et al.  Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta , 2020, Scientific Reports.

[32]  J. Weber,et al.  Cannabis use in pregnancy and breastfeeding: The pharmacist’s role , 2020, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

[33]  O. Manzoni,et al.  Sex‐specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212‐2 depend on mGlu5 receptor signalling , 2020, British journal of pharmacology.

[34]  D. Barch,et al.  Prenatal cannabis exposure and childhood outcomes: Results from the ABCD study , 2019 .

[35]  M. Javadi-Paydar,et al.  Vapor inhalation of cannabidiol (CBD) in rats , 2019, Pharmacology Biochemistry and Behavior.

[36]  O. Manzoni,et al.  Sex Differences in the Behavioral and Synaptic Consequences of a Single in vivo Exposure to the Synthetic Cannabimimetic WIN55,212-2 at Puberty and Adulthood , 2019, Front. Behav. Neurosci..

[37]  Ethan B. Russo.  The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain , 2019, Front. Plant Sci..

[38]  K. Vinod,et al.  Cannabinoid exposure during pregnancy and its impact on immune function , 2018, Cellular and Molecular Life Sciences.

[39]  A. Iwasaki,et al.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development. , 2018, Immunity.

[40]  D. Frommhold,et al.  LPS-induced maternal inflammation promotes fetal leukocyte recruitment and prenatal organ infiltration in mice , 2018, Pediatric Research.

[41]  K. Mackie,et al.  Sex-dependent effects of in utero cannabinoid exposure on cortical function , 2018, eLife.

[42]  J. Howland,et al.  Prospective Analysis of the Effects of Maternal Immune Activation on Rat Cytokines during Pregnancy and Behavior of the Male Offspring Relevant to Schizophrenia , 2018, eNeuro.

[43]  R. Nibbs,et al.  A guide to chemokines and their receptors , 2018, The FEBS journal.

[44]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[45]  T. Burbacher,et al.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development , 2017, Pharmacology & therapeutics.

[46]  O. Abulseoud,et al.  Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake. , 2016, Clinical chemistry.

[47]  T. Oreshkova,et al.  Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity , 2016, Journal of pregnancy.

[48]  J. Gunn,et al.  Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis , 2016, BMJ Open.

[49]  C. McBain,et al.  Persistent inhibitory circuit defects and disrupted social behavior following in utero exogenous cannabinoid exposure , 2016, Molecular Psychiatry.

[50]  B. Lutz,et al.  Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons , 2015, Proceedings of the National Academy of Sciences.

[51]  R. Laprairie,et al.  Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor , 2015, British journal of pharmacology.

[52]  J. Gunn,et al.  The effects of prenatal cannabis exposure on fetal development and pregnancy outcomes: a protocol , 2015, BMJ Open.

[53]  Dajin Li,et al.  The integrative roles of chemokines at the maternal–fetal interface in early pregnancy , 2014, Cellular and Molecular Immunology.

[54]  L. Manwell,et al.  A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents. , 2014, Journal of pharmacological and toxicological methods.

[55]  A. Brusco,et al.  Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex , 2014, Journal of neurochemistry.

[56]  A. Alpár,et al.  Miswiring the brain: Δ9‐tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin‐2 degradation pathway , 2014, The EMBO journal.

[57]  Ethan B. Russo.  Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects , 2011, British journal of pharmacology.

[58]  M. Janahmadi,et al.  Maternal exposure to the CB1 cannabinoid agonist WIN 55212–2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring , 2011, Neuroscience.

[59]  I. McGregor,et al.  A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. , 2010, The international journal of neuropsychopharmacology.

[60]  L. Ferraro,et al.  Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions , 2009, Journal of Neural Transmission.

[61]  L. Salamonsen,et al.  Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. , 2007, Seminars in reproductive medicine.

[62]  M. Huestis.  Human Cannabinoid Pharmacokinetics , 2007, Chemistry & biodiversity.

[63]  S. Sonis,et al.  The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. , 2007, Cancer treatment reviews.

[64]  R. Pertwee,et al.  Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro , 2007, British journal of pharmacology.

[65]  K. Mackie,et al.  The emerging functions of endocannabinoid signaling during CNS development. , 2007, Trends in pharmacological sciences.

[66]  G. Schulte,et al.  Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[67]  L. Ferraro,et al.  Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. , 2005, Cerebral cortex.

[68]  K. Trybus.  No strain, no gain , 2005, Nature Cell Biology.

[69]  J. Sullivan,et al.  Cannabinoid receptors , 2002, Current Biology.

[70]  K. Red-Horse,et al.  Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles. , 2001, The American journal of pathology.

[71]  J. Kingdom,et al.  Macrophage-Induced Apoptosis Limits Endovascular Trophoblast Invasion in the Uterine Wall of Preeclamptic Women , 2001, Laboratory Investigation.

[72]  T. Bonner,et al.  Dysregulated Cannabinoid Signaling Disrupts Uterine Receptivity for Embryo Implantation* , 2001, The Journal of Biological Chemistry.

[73]  F. Molina-Holgado,et al.  Maternal Exposure to Δ 9-Tetrahydrocannabinol (Δ 9-THC) Alters Indolamine Levels and Turnover in Adult Male and Female Rat Brain Regions , 1997, Brain Research Bulletin.

[74]  F. P. Nestel,et al.  Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. , 1990, Journal of reproduction and fertility.

[75]  W. Slikker,et al.  Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. , 1987, Toxicology and applied pharmacology.

[76]  Stuart L Jones,et al.  THE PHARMACIST'S ROLE , 1984, The Lancet.

[77]  P. Morales,et al.  Molecular Targets of the Phytocannabinoids: A Complex Picture. , 2017, Progress in the chemistry of organic natural products.

[78]  A. Howlett,et al.  CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.

[79]  D. Dow-Edwards,et al.  Prenatal tetrahydrocannabinol (THC) alters cognitive function and amphetamine response from weaning to adulthood in the rat. , 2012, Neurotoxicology and teratology.

[80]  R. Pertwee.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. , 2008, British journal of pharmacology.

[81]  R. Greco.  The protocol , 2008, Nature.

[82]  Jun-Ming Zhang,et al.  Cytokines, Inflammation, and Pain , 2007, International anesthesiology clinics.

[83]  B. Cravatt,et al.  The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells , 2006, The Journal of Neuroscience.

[84]  Alison Mackey.  A Complex Picture? , 2002 .

[85]  M. Subramanian,et al.  Effects of low doses of alcohol on delta-9-tetrahydrocannabinol's effects in pregnant rats. , 1990, Life sciences.

[86]  B. Martin,et al.  Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. , 1989, Life sciences.

[87]  Robert C. Wolpert,et al.  A Review of the , 1985 .